MWM
KRYS icon

Mindset Wealth Management’s Krystal Biotech KRYS Stock Holding History

Mindset Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Buy
1,600
+150
+10% +$44.8K 0.11% 89
2026
Q1 		$375K Sell
1,450
-343
-19% -$91.3K 0.1% 106
2025
Q4 		$442K Buy
1,793
+323
+22% +$68K 0.12% 97
2025
Q3 		$259K Buy
+1,470
New +$220K 0.07% 139
2025
Q2 		– Sell
-1,450
Closed -$261K – 158
2025
Q1 		$261K Buy
+1,450
New +$244K 0.1% 104

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mindset Wealth Management's KRYS Position: Q2 2026 in Review

Mindset Wealth Management increased its Krystal Biotech (KRYS) stake by 10% in Q2 2026, buying an estimated $44.8K and bringing the position to 1,600 shares worth $595K. The position accounts for 0.11% of the portfolio, ranked #89.

Mindset Wealth Management first reported a position in KRYS in Q1 2025 and has held it in 5 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Mindset Wealth Management held 1,600 shares of Krystal Biotech worth $595K as of Q2 2026.
  • Mindset Wealth Management bought 150 Krystal Biotech shares in Q2 2026, an estimated $44.8K.
  • Krystal Biotech made up 0.11% of Mindset Wealth Management's portfolio in Q2 2026, its #89 holding.
  • Mindset Wealth Management first reported a position in Krystal Biotech in Q1 2025 and has held it in 5 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Mindset Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.